Misc - Other  2001

TCTMD Slide Sets

• Catheter Closure of the Patent Foramen Ovale in the Adult Patient by B. Meier
• Cryptogenic Stroke: Percutaneous Closure of ASD/PFO, by R.J. Sommer
• Revascularization in the Diabetic and Nondiabetic Patient: Medical Therapy, Angioplasty or Surgery by W.W. O'Neill
• Diabetics and Interventional Cardiology, by S.P. Marso
• Revascularization Strategies in the Patient with Chronic Renal Insufficiency by D. R. Holmes, Jr.

Editorial
How should patients with patent foramen ovale be managed?
Alp N, et al.
Heart 2001;85:242-4
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11179251

CME Cardiology Program 
Release Date: January 16, 2001
Valid for CME until January 16, 2002

• Insights - Managing Cardiovascular Disease in Women: Role of Clinical and Interventional Cardiology 
  Dean J. Kereiakes, MD, FACC; Elsa-Grace V. Giardina, MD, FACC, FACP; Alexandra J. Lansky, MD; A. Michael Lincoff, MD, FACC; Gilles Montalescot, MD, PhD

Online Course
Diabetes & Coronary Interventions
http://www.tctmd.com/product-education/one.html?education_id=343
The following course is designed for clinical and interventional cardiologists and researchers interested in diabetes as it relates to coronary intervention. 
At the conclusion of this program, the participant should be able to do the following:

• Summarize the risk profile of patients with diabetes undergoing percutaneous coronary interventions (PCIs).
• Describe the angiographic characteristics of coronary-artery lesions in patients with and without diabetes.
• Summarize clinical data on the use of pharmacotherapy adjunctive to PCI, from the EPISTENT, ESPRIT and TARGET trials, in patients with diabetes and identify the postulated mechanisms of benefit observed with abciximab therapy.

Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease: Implications for management
Khaleeli E, et al.
Am Heart J 2001;141:637-44
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11275932
Asymptomatic diabetic persons have the same atherogenic burden of those patients with CAD without diabetes. The high prevalence of coronary calcium in asymptomatic persons with diabetes supports the need for aggressive management of diabetes and associated risk factors.
http://cardiology.medscape.com/38581.rhtml?srcmp=card-060801

MANAGEMENT OF DYSLIPIDEMIA IN ADULTS WITH DIABETES
The rationale for the treatment of diabetic dyslipidemia is discussed in detail in the American Diabetes Association (ADA) technical review
'Management of Dyslipidemia in Adults With Diabetes'.
Diabetes Care 24(1)supp: S58, 2001
http://cardiology.medscape.com/39099.rhtml?srcmp=card-061501

May 25, 2001
Outpatient stenting
http://www.theheart.org/index.cfm?doc_id=23287  
Outpatient coronary stenting became possible with advances in technology and technique in the mid-90s, but is still fairly rare in actual practice. Is simple political inertia and a lack of HCFA reimbursement stopping the procedure from enjoying wider use? Two cardiologists who offer their patients outpatient therapy, Dr Ian Gilchrist and Dr James Wilentz, discuss their approach.

Outpatient coronary stenting - what's stopping you?
Outpatient stenting is safe, it's effective, and it's already being done in a number of centers in the US. The main reason outpatient coronary stenting isn't more widespread, according to Dr William O'Neill, is insufficient reimbursement by Medicare. [April 26]
http://www.theheart.org/index.cfm?doc_id=22927

ESC 2001 Meeting Coverage

• The TIME Study: Evaluating Revascularization in the Elderly 
  Comment - 1    Comment - 2

AHA 2001 Meeting Coverage

• Off Pump Coronary Artery Bypass: Is there an Advantage?
  Dr. William E. Cohn discusses the advantages and disadvantages of off-pump coronary artery bypass  
  Click here

• Memory Outcome is Better Following Off-Pump Coronary Artery Bypass Grafting (CPB) Technique
  David Cook, MD
  Click here

Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery
Newman MF, et al.
N Engl J Med 2001;344:395-402
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11172175
The results of this study confirm the relatively high prevalence and persistence of cognitive decline after CABG and suggest a pattern of early improvement followed by a later decline that is predicted by the presence of early postoperative cognitive decline.
LEADING OPINION
Investigators at Duke University have been studying the cognitive ability of patients who undergo coronary bypass surgery.
Medscape Cardiology, 2001.
http://cardiology.medscape.com/35037.rhtml?srcmp=card-031601

"Almost half of patients suffer cognitive decline 5 years after bypass surgery"
An important study from Duke University, newly published in the NEJM, has shown that CABG with cardiopulmonary bypass is frequently associated with notable cognitive decline, both immediately post-op and at 5 years after surgery. The mainstream media were quick to report this story as well. Read Heartwire's interview with the lead author, then read what the New York Times told its readers, at these pages:
http://www.theheart.org/index.cfm?doc_id=21277
http://www.theheart.org/index.cfm?doc_id=21308

Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial
Lancet 2001;358:951-7
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11583747 

Coronary stenting in diabetic patients: Results from the ROSETTA registry
Huynh T, et al.
Am Heart J 2001;142:960-4
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11717597 

Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials
Chew DP, et al.
Circulation 2001;103:961-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11181470 

Letter Response
G. Helft et al
Circulation 2001;104 e124
http://circ.ahajournals.org/cgi/content/full/104/22/e124

Journal Review

• Defining Anticoagulant Therapy for PTCA, by D. Chew with commentary by I. Moussa